Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EGFR Inhibitor-associated Rash”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Testing effectiveness (Phase 2)Looking for participantsNCT06830863
What this trial is testing

Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

Who this might be right for
EGFR Inhibitor-associated Rash
Azitra Inc. 32
Early research (Phase 1)Study completedNCT00656786
What this trial is testing

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

Who this might be right for
EGFR Inhibitor-associated Rash
Spectrum Pharmaceuticals, Inc 18
Testing effectiveness (Phase 2)Study completedNCT04239846
What this trial is testing

Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

Who this might be right for
EGFR Inhibitor-Induced Skin Rash
TWi Biotechnology, Inc. 74
Not applicableWithdrawnNCT01349556
What this trial is testing

Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream

Who this might be right for
Medication Reaction
Johns Hopkins University
Testing effectiveness (Phase 2)Looking for participantsNCT05639933
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Who this might be right for
Acneiform Eruption Due to ChemicalXerosis CutisParonychia
Hoth Therapeutics, Inc. 152
Testing effectiveness (Phase 2)Looking for participantsNCT06818058
What this trial is testing

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

Who this might be right for
EGFR Inhibitor-associated Rash
Tarian Pharma 60
Not applicableUnknownNCT00498992
What this trial is testing

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

Who this might be right for
Dermatologic ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
Ingalls Memorial Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04759664
What this trial is testing

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Who this might be right for
EGFRI Induced Acneiform Lesions
Lutris Pharma Ltd. 117